Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simona Toscano

Showing results (11-20 of 33) with videos related to

Pageof 4
Sort By:
Journal of Clinical Medicine|February 25, 2022
Autologous Hematopoietic Stem Cell Transplantation in Multiple Sclerosis Patients: Monocentric Case Series and Systematic Review of the LiteratureFrancesco Patti, Clara Grazia Chisari, Simona Toscano, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|January 25, 2022
Correction to: Reliability of televisits for patients with mild relapsing-remitting multiple sclerosis in the COVID‑19 eraSimona Toscano, Francesco Patti, Clara Grazia Chisari, et al.
Current Neuropharmacology|November 12, 2021
Changes in John Cunningham Virus Index in Multiple Sclerosis Patients Treated with Different Disease-Modifying TherapiesEleonora Sgarlata, Clara Grazia Chisari, Simona Toscano, et al.
Multiple Sclerosis and Related Disorders|January 23, 2023
Pregnancy planning and management for women with multiple sclerosis: what has changed over the last 15 years? An Italian single-center experienceSimona Toscano, Clara Grazia Chisari, Adriana Meli, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|January 12, 2022
Reliability of televisits for patients with mild relapsing-remitting multiple sclerosis in the COVID-19 eraSimona Toscano, Francesco Patti, Clara Grazia Chisari, et al.
Multiple Sclerosis and Related Disorders|November 25, 2018
Effectiveness and safety of Rituximab in demyelinating diseases spectrum: An Italian experienceEmanuele D'Amico, Aurora Zanghì, Clara Grazia Chisari, et al.
Expert Opinion on Drug Safety|August 21, 2019
An update on the safety of treating relapsing-remitting multiple sclerosisClara G Chisari, Simona Toscano, Emanuele D'Amico, et al.
Multiple Sclerosis and Related Disorders|February 15, 2022
Factors driving delayed time to multiple sclerosis diagnosis: Results from a population-based studyFrancesco Patti, Clara Grazia Chisari, Sebastiano Arena, et al.
Environmental Research|July 3, 2020
CSF neurotoxic metals/metalloids levels in amyotrophic lateral sclerosis patients: comparison between bulbar and spinal onsetFrancesco Patti, Maria Fiore, Clara G Chisari, et al.
Multiple Sclerosis and Related Disorders|November 11, 2023
Cerebrospinal fluid neurofilament light chains predicts early disease-activity in Multiple SclerosisSimona Toscano, Vittorio Oteri, Clara Grazia Chisari, et al.
Pageof 4

Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
Journal of Clinical Medicine|February 25, 2022
Autologous Hematopoietic Stem Cell Transplantation in Multiple Sclerosis Patients: Monocentric Case Series and Systematic Review of the LiteratureFrancesco Patti, Clara Grazia Chisari, Simona Toscano, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|January 25, 2022
Correction to: Reliability of televisits for patients with mild relapsing-remitting multiple sclerosis in the COVID‑19 eraSimona Toscano, Francesco Patti, Clara Grazia Chisari, et al.
Current Neuropharmacology|November 12, 2021
Changes in John Cunningham Virus Index in Multiple Sclerosis Patients Treated with Different Disease-Modifying TherapiesEleonora Sgarlata, Clara Grazia Chisari, Simona Toscano, et al.
Multiple Sclerosis and Related Disorders|January 23, 2023
Pregnancy planning and management for women with multiple sclerosis: what has changed over the last 15 years? An Italian single-center experienceSimona Toscano, Clara Grazia Chisari, Adriana Meli, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|January 12, 2022
Reliability of televisits for patients with mild relapsing-remitting multiple sclerosis in the COVID-19 eraSimona Toscano, Francesco Patti, Clara Grazia Chisari, et al.
Multiple Sclerosis and Related Disorders|November 25, 2018
Effectiveness and safety of Rituximab in demyelinating diseases spectrum: An Italian experienceEmanuele D'Amico, Aurora Zanghì, Clara Grazia Chisari, et al.
Expert Opinion on Drug Safety|August 21, 2019
An update on the safety of treating relapsing-remitting multiple sclerosisClara G Chisari, Simona Toscano, Emanuele D'Amico, et al.
Multiple Sclerosis and Related Disorders|February 15, 2022
Factors driving delayed time to multiple sclerosis diagnosis: Results from a population-based studyFrancesco Patti, Clara Grazia Chisari, Sebastiano Arena, et al.
Environmental Research|July 3, 2020
CSF neurotoxic metals/metalloids levels in amyotrophic lateral sclerosis patients: comparison between bulbar and spinal onsetFrancesco Patti, Maria Fiore, Clara G Chisari, et al.
Multiple Sclerosis and Related Disorders|November 11, 2023
Cerebrospinal fluid neurofilament light chains predicts early disease-activity in Multiple SclerosisSimona Toscano, Vittorio Oteri, Clara Grazia Chisari, et al.
Pageof 4